Articles & News

Behind the scenes at Proxima Clinical Research

Proxima CRO Blog

Isabella Schmitt of Proxima Clinical Research Named A Woman to Watch Honoree of Houston Business Journal 2021 Women Who Mean Business

Check out Isabella Schmitt's interview! This year, she is one of the Women to Watch honoree's of the Houston Business Journal 2021, Women Who Mean Business

October 22, 2021

The growing femtech industry needs more attention — and funds, says this Houston expert

Read our Director of Regulatory Affairs, Isabella Schmitt, talk about femtech & investments in the recent Innovation Map Article.

Fresh off a $1.4B exit, this Houston innovator is focused on funding medical device tech

Check out Larry's latest interview with Innovation Map talking about his startup's recent exit, his role on the boards of five med device companies, his investment activity, and his work at Proxima.

Proxima Clinical Research Recognized by Great Place to Work® on Certification Nation Day

Proxima Clinical Research Receives the 2021 Great Places To Work Certification. We Help Our Innovative MedTech Clients Through The FDA’s Approval Process With Talented Team of FDA Consultants.

Proxima Clinical Research Named 2021 Best Place to Work by Modern Healthcare

Proxima Clinical Research has been named by Modern Healthcare as one of the 2021 Best Places to Work in Healthcare.

Global Medical Device Podcast: Comparing FDA's Breakthrough Devices Program & Safer Technologies Program

What are the differences, similarities, and potential benefits of FDA’s Breakthrough Devices Program (BDP) and Safer Technologies Program for Medical Devices (STeP)?

Houston health tech company bounces back from COVID-19 in a big way

Check out Kevin's latest interview with Innovation Map talking all things Proxima & growth during a very uncertain pandemic.

Tackling ISO 10993-12 Biocompatibility

Clear Up The Confusion Of Medical Device Biocompatibility Testing Requirements By Discovering The 4 Step Process Of ISO 10993-12.

Breakthrough Device Designation Reimbursement

Learn What Breakthrough Device Designation Is & Why the Automatic BDD Reimbursement Been Paused by the Centers for Medicare & Medicaid Services (CMS).‍

Proxima Clinical Research Experiences Fast Growth Following Brief Covid-19 Dip

CRO doubles clients and triples clinical studies and staff over last nine months to bring hundreds of innovative healthcare products from concept to market, faster.